BR9606668A - Piridazinonas como antagonista de receptor-endotelina - Google Patents
Piridazinonas como antagonista de receptor-endotelinaInfo
- Publication number
- BR9606668A BR9606668A BR9606668A BR9606668A BR9606668A BR 9606668 A BR9606668 A BR 9606668A BR 9606668 A BR9606668 A BR 9606668A BR 9606668 A BR9606668 A BR 9606668A BR 9606668 A BR9606668 A BR 9606668A
- Authority
- BR
- Brazil
- Prior art keywords
- pyridazinones
- receptor antagonist
- endothelin receptor
- endothelin
- antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19537548A DE19537548A1 (de) | 1995-10-09 | 1995-10-09 | Endothelin-Rezeptor-Antagonisten |
| PCT/EP1996/004111 WO1997013758A1 (de) | 1995-10-09 | 1996-09-19 | Pyridazinone als endothelin-rezeptor-antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9606668A true BR9606668A (pt) | 1997-09-30 |
Family
ID=7774384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9606668A BR9606668A (pt) | 1995-10-09 | 1996-09-19 | Piridazinonas como antagonista de receptor-endotelina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5883090A (pt) |
| EP (1) | EP0796250A1 (pt) |
| JP (1) | JPH10511118A (pt) |
| CN (1) | CN1168137A (pt) |
| AR (1) | AR004689A1 (pt) |
| AU (1) | AU7211996A (pt) |
| BR (1) | BR9606668A (pt) |
| CA (1) | CA2207243A1 (pt) |
| CZ (1) | CZ176897A3 (pt) |
| DE (1) | DE19537548A1 (pt) |
| HU (1) | HUP9801879A3 (pt) |
| NO (1) | NO972612L (pt) |
| PL (1) | PL320638A1 (pt) |
| SK (1) | SK73597A3 (pt) |
| WO (1) | WO1997013758A1 (pt) |
| ZA (1) | ZA968483B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6187920B1 (en) * | 1998-03-26 | 2001-02-13 | Sumitomo Chemical Co., Ltd. | Pyridazinone derivatives |
| US6670362B2 (en) * | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| GB0023074D0 (en) * | 2000-09-20 | 2000-11-01 | Pfizer Ltd | Pyridazines |
| US6996060B1 (en) | 2001-03-20 | 2006-02-07 | Arraycomm, Inc. | Closing a communications stream between terminals of a communications system |
| US7339906B1 (en) * | 2001-03-20 | 2008-03-04 | Arraycomm, Llc | Opening a communications stream between a user terminal and a base station |
| DE10155076A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen |
| RU2007106869A (ru) | 2004-08-23 | 2008-09-27 | Вайет (Us) | Тиазол-нафтиловые кислоты как ингибиторы ингибитора активации плазминогена-1 |
| WO2006023864A1 (en) * | 2004-08-23 | 2006-03-02 | Wyeth | Pyrrolo-naphthyl acids as pai-1 inhibitors |
| KR20070055563A (ko) | 2004-08-23 | 2007-05-30 | 와이어쓰 | 혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(ｐａｉ-1)의 조절제로서의옥사졸로-나프틸 산 |
| CN109867613B (zh) * | 2017-12-01 | 2021-08-17 | 中国科学院大连化学物理研究所 | 一种多取代苯甲酸及其合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2832780A (en) * | 1955-09-14 | 1958-04-29 | Warner Lambert Pharmaceutical | Hydrazides of pyridazonyl-substituted alkanoic acids |
| JPS57501328A (pt) * | 1980-08-07 | 1982-07-29 | ||
| PL176250B1 (pl) * | 1991-11-05 | 1999-05-31 | Smithkline Beecham Corp | Sposób wytwarzania pochodnych indanu |
| ZA939516B (en) * | 1992-12-22 | 1994-06-06 | Smithkline Beecham Corp | Endothelin receptor antagonists |
| EP0617001B1 (en) * | 1993-03-19 | 2000-01-26 | Merck & Co. Inc. | Phenoxyphenylacetic acid derivatives |
| DE4339868A1 (de) * | 1993-11-23 | 1995-05-24 | Merck Patent Gmbh | Imidazopyridazine |
| ES2160156T3 (es) * | 1994-03-10 | 2001-11-01 | Fujisawa Pharmaceutical Co | Derivados de naftaleno como agonistas de la prostaglandina i2. |
-
1995
- 1995-10-09 DE DE19537548A patent/DE19537548A1/de not_active Withdrawn
-
1996
- 1996-09-10 AR ARP960104655A patent/AR004689A1/es unknown
- 1996-09-19 EP EP96933341A patent/EP0796250A1/de not_active Withdrawn
- 1996-09-19 PL PL96320638A patent/PL320638A1/xx unknown
- 1996-09-19 CN CN96191388A patent/CN1168137A/zh active Pending
- 1996-09-19 CA CA002207243A patent/CA2207243A1/en not_active Abandoned
- 1996-09-19 AU AU72119/96A patent/AU7211996A/en not_active Abandoned
- 1996-09-19 WO PCT/EP1996/004111 patent/WO1997013758A1/de not_active Application Discontinuation
- 1996-09-19 BR BR9606668A patent/BR9606668A/pt not_active Application Discontinuation
- 1996-09-19 US US08/849,344 patent/US5883090A/en not_active Expired - Fee Related
- 1996-09-19 JP JP9514665A patent/JPH10511118A/ja active Pending
- 1996-09-19 HU HU9801879A patent/HUP9801879A3/hu unknown
- 1996-09-19 CZ CZ971768A patent/CZ176897A3/cs unknown
- 1996-09-19 SK SK735-97A patent/SK73597A3/sk unknown
- 1996-10-08 ZA ZA968483A patent/ZA968483B/xx unknown
-
1997
- 1997-06-06 NO NO972612A patent/NO972612L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0796250A1 (de) | 1997-09-24 |
| MX9704262A (es) | 1997-09-30 |
| CN1168137A (zh) | 1997-12-17 |
| WO1997013758A1 (de) | 1997-04-17 |
| DE19537548A1 (de) | 1997-04-10 |
| HUP9801879A3 (en) | 1999-07-28 |
| ZA968483B (en) | 1997-05-20 |
| SK73597A3 (en) | 1998-05-06 |
| CA2207243A1 (en) | 1997-04-17 |
| CZ176897A3 (en) | 1997-10-15 |
| NO972612D0 (no) | 1997-06-06 |
| NO972612L (no) | 1997-08-08 |
| US5883090A (en) | 1999-03-16 |
| JPH10511118A (ja) | 1998-10-27 |
| AR004689A1 (es) | 1999-03-10 |
| AU7211996A (en) | 1997-04-30 |
| PL320638A1 (en) | 1997-10-13 |
| HUP9801879A2 (hu) | 1999-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI960953A (fi) | Endoteliinireseptoriantagonisteja | |
| BR9610823A (pt) | Derivados de pirimidina como antagonistas do receptor | |
| BR9707391A (pt) | Pirazolpirimidinas como antagonistas de receptor de crf | |
| BR9407933A (pt) | Antagonistas de receptores de endotelina | |
| BR9206722A (pt) | Antagonista receptores de endotelina | |
| BR9712248A (pt) | Antagonista receptores de vitronectina | |
| NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| ATE263151T1 (de) | Indolderivate verwendbar als endothelinrezeptorantagonisten | |
| FI960516A0 (fi) | Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja | |
| DE69429861T2 (de) | Endothelin-rezeptor-antagonisten | |
| ZA969775B (en) | Endothelin receptor antagonists. | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| BR9507220A (pt) | Antagonistas de receptores de endotelina | |
| NO20000542D0 (no) | Endothelin-antagonister | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| PT854867E (pt) | Tetra-hidroquinolinas como antagonistas de nmda | |
| BR9606668A (pt) | Piridazinonas como antagonista de receptor-endotelina | |
| DZ2322A1 (fr) | Antagonistes de récepteurs de vitronectine. | |
| BR9609914A (pt) | Antagonista do receptor de endotelina | |
| HU9602054D0 (en) | Endothelin receptor antagonists | |
| EP0854721A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS | |
| ZA966552B (en) | Endothelin receptor antagonists. | |
| BR9603432A (pt) | Antagonistas de receptores de endotelina | |
| EP0841926A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| FA8 | Dismissal: dismissal - article 36, par. 1 of industrial property law |